These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1695222)

  • 41. Optimization of the EC26-2A4 Epitope in the gp41 Membrane Proximal External Region Targeted by Neutralizing Antibodies from an Elite Controller.
    Ringel O; Müller K; Koch J; Brill B; Wolf T; Stephan C; Vieillard V; Debré P; Dietrich U
    AIDS Res Hum Retroviruses; 2018 Apr; 34(4):365-374. PubMed ID: 29262692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mouse monoclonal antibody 5-21-3 recognizes a contiguous, conformation-dependent epitope and maps to a hydrophilic region in HIV-1 gp41.
    Hunt JC; Desai SM; Casey JM; Bolling TJ; Leung TK; Decker RH; Devare SG; Sarin V
    AIDS Res Hum Retroviruses; 1990 May; 6(5):587-98. PubMed ID: 1694451
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the alpha-helix of gp41.
    Clerici M; Barassi C; Devito C; Pastori C; Piconi S; Trabattoni D; Longhi R; Hinkula J; Broliden K; Lopalco L
    AIDS; 2002 Sep; 16(13):1731-41. PubMed ID: 12218383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multifaceted consequences of anti-gp41 monoclonal antibody 2F5 binding to HIV type 1 virions.
    Neurath AR; Strick N; Lin K; Jiang S
    AIDS Res Hum Retroviruses; 1995 Jun; 11(6):687-96. PubMed ID: 7576928
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products.
    Pollock BJ; McKenzie AS; Kemp BE; McPhee DA; D'Apice AJ
    Clin Exp Immunol; 1989 Dec; 78(3):323-8. PubMed ID: 2482145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitope contiguous chains and antibody recognition in HIV-1 synthetic peptide antigens.
    Aleanzi M; Perotti N; Montaner A; Lottersberger J; Tonarelli G; Marcipar A
    J Mol Recognit; 1996; 9(5-6):631-8. PubMed ID: 9174949
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay.
    Opalka D; Pessi A; Bianchi E; Ciliberto G; Schleif W; McElhaugh M; Danzeisen R; Geleziunas R; Miller M; Eckert DM; Bramhill D; Joyce J; Cook J; Magilton W; Shiver J; Emini E; Esser MT
    J Immunol Methods; 2004 Apr; 287(1-2):49-65. PubMed ID: 15099755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic utility of a mouse monoclonal antibody (5-21-3) employed as a competitive probe in an immunoassay to detect antibody to HIV-1 gp41.
    Hunt JC; Falk L; Webber JS; Decker RH; Devare SG; Dawson GJ
    AIDS Res Hum Retroviruses; 1990 May; 6(5):599-606. PubMed ID: 1694452
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the mechanism of complement-mediated inhibition of antibody binding to HIV gp41.
    Hidvégi T; Prohászka Z; Ujhelyi E; Thielens NM; Dierich MP; Hampl H; Arlaud G; Nagy K; Füst G
    Clin Exp Immunol; 1993 Dec; 94(3):490-3. PubMed ID: 8252810
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type I.
    Teeuwsen VJ; Siebelink KH; Crush-Stanton S; Swerdlow B; Schalken JJ; Goudsmit J; van de Akker R; Stukart MJ; Uytdehaag FG; Osterhaus AD
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):381-92. PubMed ID: 1692724
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1.
    Prigent S; Goossens D; Clerget-Raslain B; Bahraoui E; Roussel M; Tsikas G; Laurent A; Montagnier L; Salmon C; Gluckman JC
    AIDS; 1990 Jan; 4(1):11-9. PubMed ID: 2156527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular mimicry accompanying HIV-1 infection: human monoclonal antibodies that bind to gp41 and to astrocytes.
    Eddleston M; de La Torre JC; Xu JY; Dorfman N; Notkins A; Zolla-Pazner S; Oldstone MB
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):939-44. PubMed ID: 7506553
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies.
    Tyler DS; Stanley SD; Zolla-Pazner S; Gorny MK; Shadduck PP; Langlois AJ; Matthews TJ; Bolognesi DP; Palker TJ; Weinhold KJ
    J Immunol; 1990 Nov; 145(10):3276-82. PubMed ID: 1700004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibodies to HTLV-III451 gp41: delineation of an immunoreactive conserved epitope in the transmembrane region of divergent isolates of HIV-1.
    Veronese FD; Rahman R; Kalyanaraman VS; Pal R; Lusso P; Tritch R; Petteway S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1989 Oct; 5(5):479-86. PubMed ID: 2480151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary in vitro immunization with multimeric synthetic peptides of HIV-1 envelope glycoproteins: generation of neutralizing human monoclonal antibodies.
    Fraisier C; Ebersold A; Blomberg J; Desgranges C
    J Immunol Methods; 1994 Nov; 176(1):9-22. PubMed ID: 7963597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. B cell antigenic site mapping of HIV-1 glycoproteins.
    Neurath AR
    Chem Immunol; 1993; 56():34-60. PubMed ID: 8452653
    [No Abstract]   [Full Text] [Related]  

  • 60. Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire.
    de Haard JJ; Kazemier B; Oudshoorn P; Boender P; van Gemen B; Koolen MJ; van der Groen G; Hoogenboom HR; Arends JW
    J Gen Virol; 1998 Dec; 79 ( Pt 12)():2883-94. PubMed ID: 9880001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.